Therapeutic Use of Tolvaptan in Cancer-Related Hyponatremia: Benefits, Risks, and Clinical Guidance. International Journal of Emerging Research in Applied Medical Sciences, [S. l.], v. 2, n. 4, p. 10–18, 2026. DOI: 10.65477/j29hcv64. Disponível em: https://ijerams.org/index.php/files/article/view/33. Acesso em: 12 jul. 2026.